Aquestive therapeutics to present positive topline data from pharmacokinetic and pharmacodynamic studies of anaphylm ™ (epinephrine) sublingual film at aspen allergy conference

Warren, n.j., july 25, 2023 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (the “company” or “aquestive”), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today announced that two posters recapping the positive topline data from pharmacokinetic (pk) and pharmacodynamic (pd) studies of anaphylm epinephrine sublingual film will be presented at the aspen allergy conference, which will be held from july 30 – august 3 in aspen, co.
AQST Ratings Summary
AQST Quant Ranking